Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2008-04-02
Original market date: See footnote 1
1974-12-31
Product name:
NEO ESTRONE TAB 1.25MG
DIN:
00287733
Product Monograph/Veterinary Labelling:
Date:
2004-01-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
NEOLAB INC
31 B
665 Millway Avenue
Concord
Ontario
Canada
L4K 3T8
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:16.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03CA NATURAL AND SEMISYNTHETIC ESTROGENS, PLAIN
Active ingredient group (AIG) number:See footnote5
0106444001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ESTERIFIED ESTROGENS | 1.25 MG |